Experiment 361024

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeEXTERNAL
OrganismEmpty organism
CitationELLISON,N: LOPRINZI,CL: KUGLER,J: HATFIELD,AK: MISER,A: SLOAN,JA: WENDER,DB: ROWLAND,KM: MOLINA,R: CASCINO,TL: VUKOV,AM: DHALIWAL,HS: GHOSH,C:. (1997). PHASE III PLACEBO-CONTROLLED TRIAL OF CAPSAICIN CREAM IN THE MANAGEMENT OF SURGICAL NEUROPATHIC PAIN IN CANCER PATIENTS.. 15(8)
Amount utilized
Compound isolated
DiseasePHASE III STUDY OF EFFICACY IN TREATING SURGICL NEUROPATHIC PAIN IN 99 CANCER PATIENTS. PATIENTS PREFERRED CMPD TO PLACEBO BY 3:1 MARGIN. SIDE EFFECTS INCLUDED BURNING, REDNESS AND COUGHING.
Dose amount0.075
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionCONC USED